Accolade Stock Today
| ACCD Stock | USD 3.86 0.11 2.93% |
Performance0 of 100
| Odds Of DistressOver 78
|
Accolade is trading at 3.86 as of the 30th of November 2024, a 2.93 percent increase since the beginning of the trading day. The stock's lowest day price was 3.77. Accolade has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. Equity ratings for Accolade are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 1st of September 2024 and ending today, the 30th of November 2024. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 2nd of July 2020 | Category Healthcare | Classification Health Care |
Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. Accolade, Inc. was incorporated in 2007 and is headquartered in Plymouth Meeting, Pennsylvania. The company has 80.54 M outstanding shares of which 3.64 M shares are presently shorted by private and institutional investors with about 2.82 trading days to cover. More on Accolade
Moving together with Accolade Stock
Moving against Accolade Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Accolade Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| Chief President | Kelsi Harris | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Technology, Health Care Equipment & Services, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Health Care Technology, Health Information Services, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsAccolade can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Accolade's financial leverage. It provides some insight into what part of Accolade's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Accolade (ACCD) is traded on NASDAQ Exchange in USA. It is located in 1201 Third Avenue, Seattle, WA, United States, 98101 and employs 2,400 people. Accolade is listed under Health Care Technology category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 310.87 M. Accolade conducts business under Health Care Technology sector and is part of Health Care industry. The entity has 80.54 M outstanding shares of which 3.64 M shares are presently shorted by private and institutional investors with about 2.82 trading days to cover.
Accolade currently holds about 330.63 M in cash with (16.17 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.6, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Accolade Probability Of Bankruptcy
Ownership AllocationAccolade holds a total of 80.54 Million outstanding shares. The majority of Accolade outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Accolade to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Accolade. Please pay attention to any change in the institutional holdings of Accolade as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Accolade Ownership Details
Accolade Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Geode Capital Management, Llc | 2024-09-30 | 1.8 M | |
| Clearline Capital Lp | 2024-09-30 | 1.5 M | |
| Dimensional Fund Advisors, Inc. | 2024-09-30 | 1.5 M | |
| Prosight Management, Lp | 2024-06-30 | 1.5 M | |
| D. E. Shaw & Co Lp | 2024-09-30 | 1.3 M | |
| Fairman Group Llc | 2024-09-30 | 1.1 M | |
| Jane Street Group Llc | 2024-06-30 | 1 M | |
| Whetstone Capital Advisors, Llc | 2024-09-30 | 997.9 K | |
| Goldman Sachs Group Inc | 2024-06-30 | 776.8 K | |
| Blackrock Inc | 2024-06-30 | 6.2 M | |
| Ark Investment Management Llc | 2024-09-30 | 5.4 M |
Accolade Historical Income Statement
Accolade Stock Against Markets
Accolade Corporate Management
| Richard JD | General VP | Profile | |
| Robert Cavanaugh | President | Profile | |
| Michael Hilton | Chief Officer | Profile | |
| James MD | Senior Officer | Profile | |
| Kristin Herrera | Executive Business | Profile | |
| Colin McHugh | Chief Officer | Profile | |
| Jennifer Hanson | Executive Officer | Profile |
Already Invested in Accolade?
The danger of trading Accolade is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Accolade is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Accolade. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Accolade is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Accolade is a strong investment it is important to analyze Accolade's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Accolade's future performance. For an informed investment choice regarding Accolade Stock, refer to the following important reports: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Accolade. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. For information on how to trade Accolade Stock refer to our How to Trade Accolade Stock guide.You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Accolade. If investors know Accolade will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Accolade listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.02) | Revenue Per Share 5.706 | Quarterly Revenue Growth 0.098 | Return On Assets (0.07) | Return On Equity (0.19) |
The market value of Accolade is measured differently than its book value, which is the value of Accolade that is recorded on the company's balance sheet. Investors also form their own opinion of Accolade's value that differs from its market value or its book value, called intrinsic value, which is Accolade's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Accolade's market value can be influenced by many factors that don't directly affect Accolade's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Accolade's value and its price as these two are different measures arrived at by different means. Investors typically determine if Accolade is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Accolade's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.